Pablo Gerardo Legorreta
Net Worth

Last updated:

What is Pablo Gerardo Legorreta net worth?

The estimated net worth of Mr. Pablo Gerardo Legorreta is at least $299,794,000 as of 28 Jun 2023. He owns shares worth $21,444,000 as insider and has received compensation worth at least $278,350,000 in Royalty Pharma plc.

What is the salary of Pablo Gerardo Legorreta?

Mr. Pablo Gerardo Legorreta salary is $55,670,000 per year as Founder, Chairman & Chief Executive Officer in Royalty Pharma plc.

How old is Pablo Gerardo Legorreta?

Mr. Pablo Gerardo Legorreta is 61 years old, born in 1964.

What stocks does Pablo Gerardo Legorreta currently own?

As insider, Mr. Pablo Gerardo Legorreta owns shares in one company:

Company Title Shares Price per share Total value
Royalty Pharma plc (RPRX) Founder, Chairman & Chief Executive Officer 600,000 $35.74 $21,444,000

What does Royalty Pharma plc do?

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

RPRX logo
RPRX
Royalty Pharma plc
$35.74

Pablo Gerardo Legorreta insider trading

Royalty Pharma plc

Transaction Date Security Shares Price per share Total value Source
Purchase
Class A ordinary shares 130,000 $29.51 $3,836,820
Purchase
Class A ordinary shares 45,000 $32.78 $1,474,920
Purchase
Class A ordinary shares 45,000 $33 $1,484,955
Purchase
Class A ordinary shares 150,000 $32.25 $4,837,500
Purchase
Class A ordinary shares 69,612 $32.94 $2,293,089
Purchase
Class A ordinary shares 160,388 $33.57 $5,383,744
Purchase
Class A Ordinary Shares 10,000 $28 $280,000

Royalty Pharma key executives

Royalty Pharma plc executives and other stock owners filed with the SEC: